RedHill Biopharma | DEBITO



Debt Cambiamento Data
Clal Biotechnology ILS 35.76M 28.27M 2023-12
Compugen USD 2.91M 2.91M 2024-12
Cronos Group USD 0 1.85M 2024-12
Intra Cellular Therapies USD 0 0 2024-12
RedHill Biopharma USD 558K 615K 2024-06



RedHill Biopharma DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.